SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-19-000195
Filing Date
2019-06-17
Accepted
2019-06-17 15:58:24
Documents
7
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6-K avricore6kfeb2019.htm 6-K 8577
2 NEWS REPORT ex99-1.htm EX-99 24098
3 MATERIAL CHANGE REPORT ex99-2.htm EX-99 11206
4 NEWS REPORT ex99-3.htm EX-99 7562
5 MATERIAL CHANGE REPORT ex99-4.htm EX-99 11764
6 ex9911.jpg GRAPHIC 6937
7 ex9931.jpg GRAPHIC 6937
  Complete submission text file 0001052918-19-000195.txt   83877
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 19901400
SIC: 2834 Pharmaceutical Preparations